Summary & Overview
CPT 3331F: Unspecified Service (No Summary Available)
CPT code 3331F is listed without an accompanying summary in the source description. Nationally, clear code definitions are essential for claims processing, quality measurement, and consistent clinical documentation; a missing summary for a CPT code can impede those processes and increase administrative uncertainty. This publication addresses CPT code 3331F, highlights the implications of missing descriptive information, and outlines what stakeholders typically expect when a CPT code lacks a formal descriptor.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's current documentation status, the practical impacts on billing and reporting workflows, and guidance on where to seek authoritative clarification (for example, American Medical Association resources and payer policy manuals). The report also signals what types of benchmarks and policy updates would be relevant once a formal description exists, and provides a framework for clinicians and billing staff to manage claims when code descriptions are incomplete or unavailable.
This summary is written for a national audience and focuses on administrative and policy implications rather than clinical recommendations.
Billing Code Overview
CPT code 3331F has no summary available in the source description. Service type: Data not available in the input. Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with symptomatic aortic valve disease presenting to a tertiary care hospital for evaluation and transcatheter aortic valve replacement (TAVR). The patient often has severe, symptomatic aortic stenosis with dyspnea on exertion, syncope, or heart failure symptoms and is considered high or intermediate surgical risk due to age, frailty, or comorbidities. Pre-procedure workflow includes multidisciplinary valve clinic evaluation, transthoracic and/or transesophageal echocardiography, CT angiography for annular sizing and vascular access assessment, shared decision-making with cardiothoracic surgery, and informed consent. On the day of the procedure, arterial access (typically transfemoral) is obtained in a cardiac catheterization suite or hybrid operating room; percutaneous large-bore introducer sheaths are placed, and the transcatheter valve is advanced and deployed across the native aortic valve under fluoroscopic and echocardiographic guidance. Intraprocedural monitoring includes invasive arterial pressure, transesophageal echocardiography, hemodynamic assessment, and management of conduction disturbances. Post-procedure workflow includes vascular closure, monitoring in a post-anesthesia care unit or intensive care unit for conduction abnormalities or vascular complications, repeat echocardiography to assess valve function and paravalvular leak, and discharge planning with outpatient cardiology follow-up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional Component | When only the physician interpretation or professional portion of a service is billed separately. |
TC | Technical Component | When only the facility or technical portion of a service is billed. |
59 | Distinct Procedural Service | When a different session, anesthesia, organ system, or procedure is performed on the same day and is not normally reported together. |
78 | Unplanned Return to the Operating/Procedure Room by the Same Physician Following Initial Procedure for a Related Procedure During the Postoperative Period | When the patient requires an unplanned return to the cath lab or OR for a complication related to the initial TAVR. |
79 | Unrelated Procedure or Service by the Same Physician During the Postoperative Period | For a subsequent unrelated procedure performed during the global period. |
GA | Waiver of Liability Statement on File (Advance Beneficiary Notice on File) | When a voluntary ABN/waiver of liability has been obtained for non-covered items or services. |
Modifier 22 | Increased Procedural Services | When work required is substantially greater than typically required (e.g., complex annular anatomy, extensive calcification requiring additional maneuvers). |
Modifier 51 | Multiple Procedures | When multiple procedures are performed at the same session and payer requires multiple-procedure reporting adjustments. |
Modifier 53 | Discontinued Procedure | When the procedure is started but discontinued due to patient condition or complication prior to completion. |
Modifier 62 | Two Surgeons | When two surgeons with distinct, documented roles perform portions of the procedure concurrently due to complexity. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RC0000X | Cardiovascular Disease | Interventional cardiologists who perform TAVR and pre/post procedural management. |
| 2080P0206X | Cardiothoracic Surgery | Surgeons who perform surgical aortic valve replacement and participate in heart team decision-making and hybrid procedures. |
| 2084P0800X | Interventional Cardiology | Physicians specializing in catheter-based structural heart interventions. |
| 363A00000X | Vascular Surgery | Surgeons who manage complex vascular access or treat vascular complications. |
| 207K00000X | Cardiology (General) | General cardiologists involved in diagnosis, longitudinal care, and echocardiographic evaluation. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
I35.0 | Nonrheumatic aortic (valve) stenosis | Primary indication for transcatheter or surgical aortic valve replacement due to obstruction of left ventricular outflow. |
I35.1 | Nonrheumatic aortic (valve) regurgitation | Aortic insufficiency that may require valve replacement if severe and symptomatic. |
I06.0 | Rheumatic aortic stenosis | Less common in developed settings but clinically relevant for valve replacement decisions. |
I08.0 | Nonrheumatic aortic stenosis with mitral (valve) stenosis | Represents multivalvular disease that may alter procedural planning. |
I97.120 | Postprocedural aortic valve replacement malfunction | Used for post-procedural complications and follow-up coding when valve dysfunction occurs. |
I50.9 | Heart failure, unspecified | Common presenting syndrome driving evaluation and intervention for severe valvular disease. |
R55 | Syncope and collapse | Symptom associated with severe aortic stenosis influencing urgency of intervention. |
Z95.2 | Presence of prosthetic heart valve | Relevant for patients with prior valve prostheses and for procedural planning. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
33405 | Replacement, aortic valve, with cardiopulmonary bypass; with prosthesis (mechanical or tissue) | Surgical aortic valve replacement is the open-surgical alternative to TAVR and considered during heart team evaluation. |
33426 | Replacement, aortic valve; with cardiopulmonary bypass, with prosthesis; with replacement of aortic root or ascending aorta | Performed when concurrent aortic root or ascending aorta repair is required; considered in complex anatomic cases. |
93452 | Left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, during cardiac catheterization including coronary angiography, when performed | Diagnostic coronary angiography is commonly performed prior to or during TAVR to assess coronary anatomy and guide revascularization decisions. |
92920 | Percutaneous transluminal coronary angioplasty; single major coronary artery or branch | Coronary intervention often performed before or at the time of TAVR for significant obstructive coronary disease. |
93503 | Injection procedure during cardiac catheterization including congenital cardiac shunts (diagnostic), transcatheter valve implantation guidance (note: code typically used for catheterization imaging/contrast injection) | Intraprocedural imaging and contrast injections used for valve positioning and angiographic assessment during TAVR. |
76937 | Ultrasound guidance for vascular access (e.g., central venous, arterial) | Ultrasound guidance for femoral arterial access is commonly used to reduce vascular complications. |